55
Participants
Start Date
January 31, 2009
Primary Completion Date
August 31, 2018
Study Completion Date
August 31, 2018
Dasatinib and Paclitaxel
"A treatment cycle will consist of 28 days, according to the following schedule:~Dasatinib 120MG PO once daily, Weekly paclitaxel 80 mg/m2 given intravenously over 1 hour on day 1, 8, and 15 of a 28 day cycle.~The trial will initially test the combination of weekly paclitaxel and dasatinib given PO, once daily , continuously. In case of 2 dose-limiting toxicities (DLT) in the first cohort (0), the next cohort will test dasatinib given with a different schedule, 5 days on and 2 days off, omitting dasatinib the day prior and the day of administration of paclitaxel."
Memorial Sloan Kettering Cancer Center, New York
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Memorial Sloan Kettering Cancer Center
OTHER